These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29933751)

  • 21. Interaction between cadherins, vimentin, and V-set and immunoglobulin domain containing 1 in gastric-type hepatocellular carcinoma.
    Gurzu S; Sugimura H; Szederjesi J; Szodorai R; Braicu C; Kobori L; Fodor D; Jung I
    Histochem Cell Biol; 2021 Oct; 156(4):377-390. PubMed ID: 34170400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Report of Ovarian Sertoli-Leydig Cell Tumors With Heterologous Intestinal-type Glands and Alpha Fetoprotein Elevation and Review of the Literature.
    Al-Hussaini M; Al-Othman Y; Hijazi E; McCluggage WG
    Int J Gynecol Pathol; 2018 May; 37(3):275-283. PubMed ID: 28582340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review.
    Horta M; Cunha TM; Marques RC; Félix A
    J Radiol Case Rep; 2014 Nov; 8(11):30-41. PubMed ID: 25926909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.
    Chao WT; Liu CH; Lai CR; Chen YJ; Chuang CM; Wang PH
    J Ovarian Res; 2018 Jun; 11(1):52. PubMed ID: 29933751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian clear cell adenocarcinoma producing alpha-fetoprotein: case report.
    Cetin A; Bahat Z; Cilesiz P; Demirbağ N; Yavuz E
    Eur J Gynaecol Oncol; 2007; 28(3):241-4. PubMed ID: 17624099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. α-Fetoprotein-producing ovarian tumor in a postmenopausal woman with germ cell differentiation.
    Meguro S; Yasuda M
    Ann Diagn Pathol; 2013 Feb; 17(1):140-4. PubMed ID: 22056036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
    Esheba GE; Pate LL; Longacre TA
    Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.
    Ramalingam P; Malpica A; Silva EG; Gershenson DM; Liu JL; Deavers MT
    Am J Surg Pathol; 2004 Nov; 28(11):1499-505. PubMed ID: 15489654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of α2,3-linked sialylation on clear cell type epithelial ovarian cancer.
    Sung PL; Wen KC; Horng HC; Chang CM; Chen YJ; Lee WL; Wang PH
    Taiwan J Obstet Gynecol; 2018 Apr; 57(2):255-263. PubMed ID: 29673670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?
    Sahin H; Meydanli MM; Sari ME; Yalcin I; Çoban G; Ozkan NT; Cuylan ZF; Erdem B; Gungorduk K; Akbayir Ö; Dede M; Salman MC; Güngör T; Ayhan A
    J Ovarian Res; 2018 Mar; 11(1):21. PubMed ID: 29506569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection.
    Dai CY; Lin CY; Tsai PC; Lin PY; Yeh ML; Huang CF; Chang WT; Huang JF; Yu ML; Chen YL
    J Chin Med Assoc; 2018 Feb; 81(2):155-163. PubMed ID: 29217359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian Yolk Sac Tumors; Does Age Matter?
    Faure Conter C; Xia C; Gershenson D; Hurteau J; Covens A; Pashankar F; Krailo M; Billmire D; Patte C; Fresneau B; Shaikh F; Stoneham S; Nicholson J; Murray M; Frazier AL
    Int J Gynecol Cancer; 2018 Jan; 28(1):77-84. PubMed ID: 29194189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant chemotherapy with tegafur/uracil for more than 1 year improves disease-free survival for low-risk Stage II colon cancer.
    Hu JM; Chou YC; Wu CC; Hsiao CW; Lee CC; Chen CT; Hu SI; Liu WT; Jao SW
    J Chin Med Assoc; 2016 Sep; 79(9):477-88. PubMed ID: 27329402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic Significance of HNF-1β, AIRD1A, and PIK3CA Expression in Ovarian Clear Cell Carcinoma: A Tissue Microarray Study of 130 Cases.
    Ye S; Yang J; You Y; Cao D; Huang H; Wu M; Chen J; Lang J; Shen K
    Medicine (Baltimore); 2016 Mar; 95(9):e3003. PubMed ID: 26945423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
    Huang W; Cheng X; Ji J; Zhang J; Li Q
    Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.